ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "278: Merger Mondays, Ozempic panic, & CRISPR'd pigs"
Episode Synopsis
We discuss Bristol Myers Squibb’s multibillion-dollar acquisition of Mirati Therapeutics and what it means for a biotech sector still in a slump. We also explain the latest news in the life sciences, including Wall Street’s freakout over GLP-1, CRISPR’ing animals, and the latest in the NASH saga.
More episodes of the podcast The Readout Loud
383: JPM to bring more deals and happy CEOs
08/01/2026
382: Biotech's year in review
18/12/2025
In God we trust